Search
for
Sort by
Research 841–870 of 1000+
- Proposing Vascepa (Icosapent Ethyl) as Supplemental Treatment Targeting the Underlying Causes of Persistent, Post-Viral Symptoms Associated with COVID-19: A Case Series
- Sa1389: LESSONS FROM HEPATITIS C TREATMENT DURING THE COVID-19 PANDEMIC: DECREASED RESOURCE UTILIZATION LEADS TO SIMILAR EFFICACY IN BRITISH COLUMBIA, CANADA
- Telogen Effluvium and Alopecia Areata as Clinical Manifestations of Covid-19
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Host Genetic Susceptibility and Impacts of Dietary Factors on Covid-19
- Nutrological control and treatment of melasma in the COVID-19 pandemic: a concise systematic review
- Role of Polycystic Ovary Syndrome in Increasing Susceptibility to COVID-19: A Biochemical and Psychological Approach
- Possibilities for correcting diffuse alopecia associated with prior coronavirus infection (COVID-19)
- Hair cortisol concentrations in medical nurses during the COVID-19
- 28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
- Whole plant Adiantum capillus-veneris linn extract as an anti-COVID-19 therapy
- P042 A rare case of constrictive pericarditis with co-existing positive COVID-19: probable autoimmune or immunoglobulin related disease
- Reporte de caso: Presentación clínica e importancia de coinfecciones durante pandemia por COVID-19 en pacientes con neoplasias malignas
- ВЛИЯНИЕ АНДРОГЕННОГО СТАТУСА И АНТИАНДРОГЕННОЙ ТЕРАПИИ НА ТЕЧЕНИЕ COVID-19 У МУЖЧИН
- Recomendaciones Rama de Dermatología Pediátrica, Sociedad Chilena de Pediatría. Pandemia COVID-19
- Literature ReviewThe Gabrin Sign and Role of Androgens in COVID-19 Severity: A Look at 3 Studies
- Is there a link between androgenetic alopecia and COVID-19?
- 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia (vol 35, pg e243, 2021)
- Raw data from JAAD research letter: Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Uncertainty, Anxiety and Isolation: Experiencing the COVID-19 Pandemic and Lockdown as a Woman with Polycystic Ovary Syndrome (PCOS)
- Factors associated with anti-SARS-CoV-2 IgG antibody production in patients convalescing from COVID-19
- Ageing, Sex, Obesity, Smoking and COVID-19—Truths, Myths and Speculations
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Heterogeneous red–white discoloration of the nail bed and distal onycholysis in a patient with COVID‐19
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- The Need for Speed and Efficiency: A Brief Review of Small Molecule Antivirals for COVID-19
- SARS-CoV-2-induced Host Metabolic Reprogram (HMR): Nutritional Interventions for Global Management of COVID-19 and Post-Acute Sequelae of COVID-19 (PASC)
- Intra-host SARS-CoV-2 single-nucleotide variants emerged during the early stage of COVID-19 pandemic forecast population fixing mutations